Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATEGLINIDE vs NEFOPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NATEGLINIDE vs NEFOPAM: Safety Overview

Metric NATEGLINIDE NEFOPAM
Total FAERS Reports 183 2,857
Deaths Reported 19 360
Death Rate 10.4% 12.6%
Hospitalizations 51 1,685
Average Patient Age 64.0 yrs 55.0 yrs
% Female Patients 60.3% 54.4%
FDA Approval Date Apr 19, 2019 N/A
Manufacturer Zydus Lifesciences Limited N/A
Route ORAL N/A
Marketing Status Discontinued N/A